全部

1·Water-soluble carboxymethyl chitosan was prepared from dried shrimp shells.

以虾壳为原料，制备了水溶性羧甲基壳聚糖。

2·Objective: to develop a synthesis method of the carboxymethyl chitosan (CM-CTS) and to study its bacteriostatic effect.

前言：目的：研究羧甲基壳聚糖的合成反应及其抑菌活性。

3·To investigate the acute oral toxicity of N, O-carboxymethyl chitosan in chicken and evaluate the security of the drug;

研究N，O-羧甲基壳聚糖对鸡的急性毒性，评价该药的安全性；

4·In the paper, an ashing method was improved to characterize the degree of carboxymethyl substitution of carboxymethyl chitosan.

本文改进了用于测定羧甲基壳聚糖羧甲基取代度的灰分分析法。

5·Objective to study the release characteristics of fluorouracil-loaded carboxymethyl chitosan microspheres (Fu-CMCS-MS) in vitro.

目的探讨对以羧甲基壳聚糖为载体的氟尿嘧啶微球体外释药特性的影响因素。

6·Objective to study the release characteristics of fluorouracil-loaded carboxymethyl chitosan microspheres (Fu-CMCS-MS) in vitro.

目的探讨羧甲基壳聚糖包药微球体的制备及体外释药特性。

7·Results the number of the adjuvant arthritis synovial cells were decreased as the concentration of O-Carboxymethyl Chitosan increased.

结果随着羧甲基几丁糖浓度的增加，类风湿性关节炎模型滑膜细胞的数量减少。

8·Objective to prepare carboxymethyl chitosan microspheres of fluorouracil (FU-CMCS-MS), and measure the releasing of FU-CMCS-MS in vitro.

目的探讨羧甲基壳聚糖包药微球体的制备及体外释药特性。

9·Objective to prepare carboxymethyl chitosan microspheres of fluorouracil (FU-CMCS-MS), and measure the releasing of FU-CMCS-MS in vitro.

目的探讨对以羧甲基壳聚糖为载体的氟尿嘧啶微球体外释药特性的影响因素。

10·Objective to study the effects of the O-Carboxymethyl Chitosan on the cultivation of synovial sells from Rabbits adjuvant arthritis in vitro.

目的研究羧甲基几丁糖对兔膝关节类风湿性关节炎模型滑膜组织细胞体外培养的影响。